0001567619-19-015537.txt : 20190731 0001567619-19-015537.hdr.sgml : 20190731 20190731163018 ACCESSION NUMBER: 0001567619-19-015537 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190731 DATE AS OF CHANGE: 20190731 EFFECTIVENESS DATE: 20190731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHIMERIX INC CENTRAL INDEX KEY: 0001117480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330903395 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-345516 FILM NUMBER: 19989161 BUSINESS ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919.806.1074 MAIL ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 D 1 primary_doc.xml X0708 D LIVE 0001117480 CHIMERIX INC 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC NORTH CAROLINA 27713 919.806.1074 DELAWARE None None Corporation true Mike Sherman 2505 Meridian Parkway, Suite 100 Durham NC NORTH CAROLINA 27713 Executive Officer Director Chief Executive Officer and President Mike Andriole 2505 Meridian Parkway, Suite 100 Durham NC NORTH CAROLINA 27713 Executive Officer Chief Business and Financial Officer W. Garrett Nichols 2505 Meridian Parkway, Suite 100 Durham NC NORTH CAROLINA 27713 Executive Officer Chief Medical Officer Michael A. Alrutz 2505 Meridian Parkway, Suite 100 Durham NC NORTH CAROLINA 27713 Executive Officer Senior Vice President, General Counsel and Corporate Secretary Randall Lanier 2505 Meridian Parkway, Suite 100 Durham NC NORTH CAROLINA 27713 Executive Officer Chief Science Officer Roy W. Ware 2505 Meridian Parkway, Suite 100 Durham NC NORTH CAROLINA 27713 Executive Officer Chief Manufacturing and Technology Officer Heather Knight-Trent 2505 Meridian Parkway, Suite 100 Durham NC NORTH CAROLINA 27713 Executive Officer Vice President of Regulatory Affairs Odin Naderer 2505 Meridian Parkway, Suite 100 Durham NC NORTH CAROLINA 27713 Executive Officer Vice President, Clinical Pharmacology and Translational Medicine Martha J. Demski 2505 Meridian Parkway, Suite 100 Durham NC NORTH CAROLINA 27713 Director James M. Daly 2505 Meridian Parkway, Suite 100 Durham NC NORTH CAROLINA 27713 Director Catherine L. Gilliss 2505 Meridian Parkway, Suite 100 Durham NC NORTH CAROLINA 27713 Director Edward F. Greissing, Jr. 2505 Meridian Parkway, Suite 100 Durham NC NORTH CAROLINA 27713 Director Patrick Machado 2505 Meridian Parkway, Suite 100 Durham NC NORTH CAROLINA 27713 Director Robert J. Meyer 2505 Meridian Parkway, Suite 100 Durham NC NORTH CAROLINA 27713 Director Fred A. Middleton 2505 Meridian Parkway, Suite 100 Durham NC NORTH CAROLINA 27713 Director Ronald C. Renaud, Jr 2505 Meridian Parkway, Suite 100 Durham NC NORTH CAROLINA 27713 Director Pharmaceuticals $5,000,001 - $25,000,000 06b false 2019-07-26 false true true The shares of common stock were issued in connection with the license of intellectual property assets. 0 34900000 34900000 0 false 1 0 0 0 false CHIMERIX INC /s/ Michael Alrutz Michael Alrutz SVP, General Counsel & Corporate Secretary 2019-07-31